Amneal Pharmaceuticals, Inc. (AMRX) › RevenueAmneal Pharmaceuticals, Inc. (AMRX) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $1.02B2017: $1.03B2018: $1.66B2019: $1.63B2020: $1.99B2021: $2.09B2022: $2.21B2023: $2.39B2024: $2.79B2025: $3.02B$3.02B2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$3.02B+8.0%2024$2.79B+16.7%2023$2.39B+8.2%2022$2.21B+5.7%2021$2.09B+5.1%2020$1.99B+22.5%2019$1.63B-2.2%2018$1.66B+60.9%2017$1.03B+1.5%2016$1.02B—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share